Tumor specific cytotoxicity and telomerase down-regulation in prostate cancer by autologous dendritic cells loaded with whole tumor cell antigens

Turkeri, LEVENT; Onol, Fikret; ÖZYÜREK, MUSTAFA

doi:10.1016/j.urolonc.2009.01.029

Tumor specific cytotoxicity and telomerase down-regulation in prostate cancer by autologous dendritic cells loaded with whole tumor cell antigens

Copy For Citation

Turkeri L., Onol F. F., ÖZYÜREK M.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, vol.28, no.3, pp.290-295, 2010 (SCI-Expanded)

Publication Type: Article / Article
Volume: 28 Issue: 3
Publication Date: 2010
Doi Number: 10.1016/j.urolonc.2009.01.029
Journal Name: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.290-295
Keywords: Prostate cancer, Dendritic cells, Immunotherapy, T-CELLS, PRESENTING CELLS, PHASE-I/II, IMMUNOTHERAPY, EXPRESSION, INDUCTION, MITOXANTRONE, LYMPHOCYTES, PREDNISONE, DOCETAXEL
Acibadem Mehmet Ali Aydinlar University Affiliated: No

Abstract

Objectives: We investigated the efficacy of cytotoxic activity of whole tumor cell-antigen loaded dendritic cells in the treatment of hormone refractory prostate cancer.